GENMARK DIAGNOSTICS INC's ticker is GNMK and the CUSIP is 372309104. A total of 151 filers reported holding GENMARK DIAGNOSTICS INC in Q2 2020. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $17,525,000 | +93.4% | 733,300 | +18.1% | 0.91% | +67.5% |
| Q4 2020 | $9,063,000 | +225.4% | 620,800 | +216.6% | 0.54% | +131.6% |
| Q3 2020 | $2,785,000 | -2.2% | 196,100 | +1.2% | 0.23% | -10.3% |
| Q2 2020 | $2,849,000 | +482.6% | 193,700 | +63.2% | 0.26% | +342.4% |
| Q1 2020 | $489,000 | +1.7% | 118,700 | +18.6% | 0.06% | +59.5% |
| Q4 2019 | $481,000 | +77.5% | 100,100 | +123.9% | 0.04% | +54.2% |
| Q3 2019 | $271,000 | +113.4% | 44,700 | +126.9% | 0.02% | +100.0% |
| Q2 2019 | $127,000 | -9.3% | 19,700 | 0.0% | 0.01% | 0.0% |
| Q1 2019 | $140,000 | +45.8% | 19,700 | 0.0% | 0.01% | +33.3% |
| Q4 2018 | $96,000 | -33.3% | 19,700 | 0.0% | 0.01% | -18.2% |
| Q3 2018 | $144,000 | +51.6% | 19,700 | +32.2% | 0.01% | +37.5% |
| Q2 2018 | $95,000 | – | 14,900 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Versor Investments LP | 2,664,831 | $63,689,000 | 3.80% |
| Chicago Capital Management, LLC | 318,113 | $7,603,000 | 3.54% |
| First Trust Capital Management L.P. | 564,758 | $13,498,000 | 2.64% |
| WATER ISLAND CAPITAL LLC | 1,693,162 | $40,467,000 | 2.47% |
| Sand Grove Capital Management LLP | 992,068 | $23,710,000 | 2.31% |
| EMC Capital Management | 121,023 | $2,892,000 | 2.06% |
| OMNI PARTNERS LLP | 1,540,671 | $36,822,000 | 1.82% |
| TIG Advisors, LLC | 1,774,849 | $42,419,000 | 1.60% |
| Cowen Prime Services LLC | 174,850 | $4,179,000 | 1.58% |
| G2 Investment Partners Management LLC | 396,400 | $9,474,000 | 1.50% |